Buy Olumiant 4mg Baricitinib

Olumiant 4mg tablets contain baricitinib, a prescription medication used for certain inflammatory conditions. This oral treatment is available in a 7-tablet pack for convenient use. Always follow healthcare provider guidance when taking Olumiant 4mg.

Strength

4mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Lilly S.A

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Olumiant 4mg tablets are used to help reduce inflammation and immune system activity in adults with moderate to severe rheumatoid arthritis. It may also be prescribed for other inflammatory conditions when recommended by a healthcare professional. Olumiant 4mg is not a first-line treatment and is typically used when other therapies have not been effective.

Side Effects

Olumiant 4mg works by targeting specific pathways in the immune system to reduce inflammation. Users may notice improvements in joint pain and swelling over time. Individual responses vary, and it may take several weeks to see the full effects of the medication.

Precautions & Warnings

Store Olumiant 4mg tablets at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the packaging is damaged or the tablets appear altered. Inform your healthcare provider about any ongoing medical conditions or medications before starting Olumiant 4mg.

Avoid Interactions

Olumiant 4mg may interact with other medications that affect the immune system, such as corticosteroids or biologics. Combining it with certain vaccines or live vaccines is not recommended. Always inform your healthcare provider about all medications, supplements, or herbal products you are taking before starting Olumiant 4mg.

References

Frequently Asked Questions

Olumiant 4mg is used to treat moderate to severe rheumatoid arthritis in adults when other therapies have not been effective.

Store Olumiant 4mg tablets at room temperature, away from moisture and heat, in their original packaging.

Olumiant 4mg may interact with other medications; always consult your healthcare provider before combining it with other drugs.

No, Olumiant 4mg contains baricitinib, which is a targeted synthetic disease-modifying antirheumatic drug (DMARD).

Individual responses vary; some users may notice improvements in symptoms within a few weeks, while others may take longer.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.